The Effect of Multimodal Treatment of Rectal Cancer on Circulating Tumor Cells: A Prospective, Observational Study

Conditions: Rectal Cancer Patients

Sex: All

Ages: 18 Years – N/A

Healthy volunteers: No

Enrollment: 150

Sponsor: The Institute of Molecular and Translational Medicine, Czech Republic

Location: University Hospital Ostrava Ostrava

Summary

The prospective study will focus on patients undergoing multimodal treatment for rectal cancer. The main objective of the study will be to monitor changes in circulating tumor cells (CTCs) in the peripheral blood of patients during multimodal treatment. For each patient enrolled in the study, peripheral blood samples will be collected at specified time intervals to determine the presence and quantity of CTCs. The CTCs levels will be compared among rectal cancer patients with neoadjuvant chemoradiotherapy and without neoadjuvant chemotherapy.

Eligibility Criteria

Inclusion Criteria: rectal cancer - Exclusion Criteria: no other cancer \-

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT07112937). StuddyBuddy aggregates publicly available trial information.